Company intelligence / Profile preview

Sundia MediTech

Shanghai, Shanghai, Chinabiospace.com ↗

Ownership: Private
Employees: ~113
Development stage: Other

Overview

Sundia MediTech is a leading China-based pre-clinical contract research organization providing comprehensive drug discovery and development services to pharmaceutical and biotech companies worldwide. Its offerings include custom synthesis, medicinal chemistry, in vitro/in vivo biology, DMPK studies, process chemistry, API manufacturing under cGMP/non-cGMP conditions, analytical development, formulation development support, and IND filing assistance[1][2][3][5].

Modalities: Small moleculePeptides
Industry: Drug Discovery Services

Partnerships

Alliance with HD BiosciencesMerged with United PharmaTech

Beyond the preview

Go deeper on Sundia MediTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sundia MediTech.

Explore the full profile